All Pharma News
UCB races to regulators after $2B rare disease bet delivers data

UCB races to regulators after $2B rare disease bet delivers data
N.P. Taylor FIERCEBIOTECH
05 Feb 2022
Share Share
Biotech funder Lightstone raises another $375M for life sciences investing

Biotech funder Lightstone raises another $375M for life sciences investing
BIOPHARMADIVE
14 Sep 2021
Share Share
Another OTC product sale for Sanofi, this one to Hypera Pharma

Another OTC product sale for Sanofi, this one to Hypera Pharma
Kevin Dunleavy FIERCEPHARMA
14 Jul 2021
Share Share
UCB Completes the Acquisition of Ra Pharmaceuticals

UCB Completes the Acquisition of Ra Pharmaceuticals
BIOSPACE
02 Apr 2020
Share Share
Ra Pharmaceuticals Announces Publication of Zilucoplan Phase 2 gMG

Ra Pharmaceuticals Announces Publication of Zilucoplan Phase 2 gMG
BUSINESSWIRE
18 Feb 2020
Share Share
Ra Pharma Announces Clearance of IND Application for the HEALEY ALS Trial

Ra Pharma Announces Clearance of IND Application for the HEALEY ALS Trial
BUSINESSWIRE
22 Jan 2020
Share Share
UCB tries to win some respect in the crowded psoriasis market

UCB tries to win some respect in the crowded psoriasis market
J. Carroll ENDPTS
18 Oct 2019
Share Share
UCB Agrees to Acquire Ra Pharmaceuticals: To Improve Treatment Options

UCB Agrees to Acquire Ra Pharmaceuticals: To Improve Treatment Options
BUSINESSWIRE
10 Oct 2019
Share Share
Ra Pharma Announces Pricing of PO of Common Stock at $32.50 per share

Ra Pharma Announces Pricing of PO of Common Stock at $32.50 per share
BIOSPACE
23 Jul 2019
Share Share
Ra Pharma Announces Positive gMG Ph 2 & Open-Label, Long-Term Extension Data

Ra Pharma Announces Positive gMG Ph 2 & Open-Label, Long-Term Extension Data
BUSINESSWIRE
07 May 2019
Share Share